Minako Takeda

Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and Mice

Masayuki Suzuki, Kiyofumi Honda, Masanori Fukazawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 164 citations

Anti‐factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation

A. Muto, Kazutaka Yoshihashi, Minako Takeda et al. · Journal of Thrombosis and Haemostasis · 2013 · 138 citations

Inflammation, Thrombosis, Immunohematology +11

Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models

M. Suzuki, Minako Takeda, A Kito et al. · Nutrition and Diabetes · 2014 · 97 citations · Full text

Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A

Atsushi Muto, Kazutaka Yoshihashi, Minako Takeda et al. · Blood · 2014 · 92 citations · Full text

Tofogliflozin, a novel sodium–glucose co‐transporter 2 inhibitor, improves renal and pancreatic function in <i>db/db</i> mice

Takumi Nagata, Taku Fukuzawa, Minako Takeda et al. · British Journal of Pharmacology · 2013 · 87 citations · Full text